CRISPR THERAPEUTICS AG shareholders Q3 2023

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$2,858,9400.96%
Hedges Asset Management LLC 22,525$1,022,4100.89%
EFG Asset Management (North America) Corp. 82,672$3,753,7220.89%
Bellevue Group AG 898,400$40,778,3760.66%
Baker Chad R 52,100$2,364,8190.60%
Sofinnova Investments, Inc. 200,000$9,078,0000.57%
Contrarius Investment Management Ltd 220,735$10,0190.56%
West Family Investments, Inc. 35,500$1,611,3450.56%
Slow Capital, Inc. 66,228$3,006,0890.55%
McGuire Investment Group, LLC 59,406$2,696,4380.52%
External links

This page lists CRISPR THERAPEUTICS AG's shareholders in Q3 2023. To view CRISPR THERAPEUTICS AG's shareholder history, click here.